Skip to main content

Avalo Therapeutics, Inc.

AVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001534120

In the last 90 days, Avalo Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $1.31B in total; no superinvestor holds it.

Holders of 5% or more of AVTX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Avalo Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of AVTX
HolderLatest formStakeChangeFirst filedLatest filingFiling
Commodore Capital LP13G9.90%5.72M sharesNewJun 18, 20261 filingJun 18, 2026SEC
TCG Crossover GP II, LLC13G7.90%3.02M sharesNewMay 12, 20261 filingMay 12, 2026SEC
Farallon Capital Management, L.L.C.13G7.40%3.97M sharesNewNov 13, 20261 filingNov 13, 2026SEC
Deep Track Capital, LP13G/A6.87%3.61M shares+1.06 ppfrom 5.81%Apr 5, 20244 filingsAug 14, 2026SEC
BlackRock, Inc.13G6.50%3.42M sharesNewJul 27, 20261 filingJul 27, 2026SEC
Ra Capital Management, L.P.13G/A6.30%3.48M shares−3.60 ppfrom 9.90%Aug 23, 20246 filingsAug 14, 2026SEC
Caligan Partners LP13G/A5.90%3.16M shares−1.30 ppfrom 7.20%Nov 14, 20254 filingsAug 14, 2026SEC
Affinity Asset Advisors, LLC13G/A5.50%2.90M shares0.00 ppfrom 5.50%Dec 31, 20245 filingsAug 13, 2026SEC
Biotechnology Value Fund L P13G/A5.30%2.80M shares−4.69 ppfrom 9.99%Aug 23, 20246 filingsAug 14, 2026SEC
Trails Edge Capital Partners, LP13G5.20%2.80M sharesNewOct 29, 20261 filingOct 29, 2026SEC
Point72 Asset Management, L.P.13G5.20%2.71M shares+1.70 ppfrom 3.50%Sep 21, 20218 filingsMay 26, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

103 Schedule 13D and 13G filings on Avalo Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on AVTX
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 13, 20268:48 AM ETFarallon Capital Management, L.L.C.and 15 others13G7.40%3.97M sharesNewSep 30, 2026SEC
Nov 10, 20266:36 AM ETState Street Corp13G4.80%2.56M shares−0.70 ppfrom 5.50%Below 5%Sep 30, 2026SEC
Nov 6, 20269:45 AM ETFMR LLCand 1 other13G/A0.90%474.4K shares−8.90 ppfrom 9.80%Below 5%Oct 30, 2026SEC
Nov 5, 20261:10 PM ETFMR LLCand 1 other13G/A9.80%5.25M shares−1.00 ppfrom 10.80%Sep 30, 2026SEC
Oct 29, 20264:15 PM ETTrails Edge Capital Partners, LPand 2 others13G5.20%2.80M sharesNewOct 22, 2026SEC
Aug 14, 20264:40 PM ETNantahala Capital Management, LLCand 2 others13G/A3.54%1.86M shares−5.85 ppfrom 9.39%Below 5%Jun 30, 2026SEC
Aug 14, 20264:40 PM ETCaligan Partners LPand 1 other13G/A5.90%3.16M shares−1.30 ppfrom 7.20%Jun 30, 2026SEC
Aug 14, 20264:38 PM ETRa Capital Management, L.P.and 3 others13G/A6.30%3.48M shares−3.60 ppfrom 9.90%Jun 30, 2026SEC
Aug 14, 20264:01 PM ETBiotechnology Value Fund L Pand 9 others13G/A5.30%2.80M shares−4.69 ppfrom 9.99%Jun 30, 2026SEC
Aug 14, 202610:39 AM ETT. Rowe Price Investment Management, Inc.13G/A0.00%3.67K shares−9.50 ppfrom 9.50%Below 5%Jun 30, 2026SEC
Aug 14, 20269:00 AM ETAvoro Capital Advisors LLCand 1 other13G/A4.44%2.33M shares−1.31 ppfrom 5.75%Below 5%Jun 30, 2026SEC
Aug 14, 20268:24 AM ETDeep Track Capital, LPand 2 others13G/A6.87%3.61M shares+1.06 ppfrom 5.81%Jun 30, 2026SEC
Aug 13, 20264:06 PM ETAffinity Asset Advisors, LLCand 1 other13G/A5.50%2.90M shares0.00 ppfrom 5.50%Jun 30, 2026SEC
Aug 7, 202611:04 AM ETFMR LLCand 1 other13G/A10.80%5.74M shares+1.10 ppfrom 9.70%Jul 31, 2026SEC
Aug 7, 20268:44 AM ETState Street Corp13G5.50%2.89M sharesNewJun 30, 2026SEC
Aug 6, 202610:14 AM ETFMR LLCand 1 other13G/A9.70%5.10M shares+3.60 ppfrom 6.10%Jun 30, 2026SEC
Jul 27, 20264:25 PM ETBlackRock, Inc.13G6.50%3.42M sharesNewJun 30, 2026SEC
Jul 6, 20265:29 PM ETMillennium Management LLCand 2 others13G/A0.00%9.86K shares−5.00 ppfrom 5.00%Below 5%Jun 30, 2026SEC
Jun 18, 20264:29 PM ETCommodore Capital LPand 3 others13G9.90%5.72M sharesNewJun 11, 2026SEC
Jun 5, 202610:13 AM ETFMR LLCand 1 other13G/A6.10%3.19M shares−6.50 ppfrom 12.60%May 29, 2026SEC
May 29, 20264:37 PM ETDeep Track Capital, LPand 2 others13G5.81%3.06M shares+5.81 ppfrom 0.00%May 22, 2026SEC
May 26, 20265:10 PM ETPoint72 Asset Management, L.P.and 2 others13G5.20%2.71M shares+1.70 ppfrom 3.50%May 22, 2026SEC
May 15, 20266:41 PM ETLogos Global Management LPand 4 others13G/A3.20%1.68M shares−2.40 ppfrom 5.60%Below 5%Mar 31, 2026SEC
May 15, 20264:34 PM ETRa Capital Management, L.P.and 3 others13G/A9.90%2.46M shares0.00 ppfrom 9.90%Mar 31, 2026SEC
May 15, 20264:31 PM ETOrbiMed Advisors LLC13G/A2.10%475.2K shares−4.30 ppfrom 6.40%Below 5%Mar 31, 2026SEC
May 15, 20264:04 PM ETBiotechnology Value Fund L Pand 9 others13G/A9.99%2.35M shares0.00 ppfrom 9.99%Mar 31, 2026SEC
May 15, 202610:31 AM ETCaligan Partners LPand 1 other13G/A7.20%1.64M shares+2.30 ppfrom 4.90%Mar 31, 2026SEC
May 15, 202610:06 AM ETT. Rowe Price Investment Management, Inc.13G9.50%2.16M sharesNewMar 31, 2026SEC
May 15, 20268:15 AM ETAvoro Capital Advisors LLCand 1 other13G5.75%1.41M sharesNewMar 31, 2026SEC
May 14, 20264:09 PM ETAffinity Asset Advisors, LLCand 1 other13G/A5.50%1.34M shares−0.20 ppfrom 5.70%Mar 31, 2026SEC
May 12, 20266:09 PM ETTCG Crossover GP II, LLCand 2 others13G7.90%3.02M sharesNewMay 5, 2026SEC
May 6, 202611:00 AM ETFMR LLCand 1 other13G/A12.60%2.88M shares+1.10 ppfrom 11.50%Mar 31, 2026SEC
Apr 1, 20261:02 PM ETLogos Global Management LPand 4 others13G5.60%1.28M sharesNewMar 26, 2026SEC
Mar 6, 202610:05 AM ETFMR LLCand 1 other13G11.50%2.13M sharesNewFeb 27, 2026SEC
Feb 24, 20264:48 PM ETMillennium Management LLCand 2 others13G5.00%934.4K shares+0.20 ppfrom 4.80%Feb 17, 2026SEC
Feb 17, 20266:13 PM ETOrbiMed Advisors LLC13G/A6.40%1.19M shares−2.50 ppfrom 8.90%Dec 31, 2025SEC
Feb 17, 20265:00 PM ETCaligan Partners LPand 1 other13G/A4.90%881.5K shares−1.40 ppfrom 6.30%Below 5%Dec 31, 2025SEC
Feb 17, 20264:33 PM ETPoint72 Asset Management, L.P.and 2 others13G/A3.50%627.5K shares−4.50 ppfrom 8.00%Below 5%Dec 31, 2025SEC
Feb 17, 20264:21 PM ETRa Capital Management, L.P.and 3 others13G/A9.90%1.94M shares0.00 ppfrom 9.90%Dec 31, 2025SEC
Feb 17, 20264:11 PM ETMillennium Management LLCand 2 others13G4.80%887.3K shares−0.10 ppfrom 4.90%Below 5%Feb 10, 2026SEC
Feb 17, 20264:07 PM ETBiotechnology Value Fund L Pand 9 others13G/A9.99%1.90M shares0.00 ppfrom 9.99%Dec 31, 2025SEC
Feb 17, 20266:57 AM ETBalyasny Asset Management LLCand 4 others13G/A2.42%439.3K shares−3.80 ppfrom 6.22%Below 5%Dec 31, 2025SEC
Feb 10, 20264:07 PM ETMillennium Management LLCand 2 others13G4.90%906.8K shares0.00 ppfrom 4.90%Below 5%Feb 3, 2026SEC
Feb 10, 202611:36 AM ETSilverarc Capital Management, LLCand 1 other13G2.83%524.4K shares−2.65 ppfrom 5.48%Below 5%Dec 31, 2025SEC
Feb 3, 20265:19 PM ETMillennium Management LLCand 2 others13G4.90%905.8K sharesNewBelow 5%Jan 28, 2026SEC
Jan 30, 20261:25 PM ETVanguard Group Inc13G/A4.43%804.1K shares−0.83 ppfrom 5.26%Below 5%Dec 31, 2025SEC
Jan 29, 20267:56 PM ETAffinity Asset Advisors, LLCand 1 other13G/A5.70%1.05M shares−1.95 ppfrom 7.65%Jan 22, 2026SEC
Nov 14, 20256:26 PM ETIkarian Capital, LLCand 1 other13G/A3.80%712.0K shares−6.19 ppfrom 9.99%Below 5%Sep 30, 2025SEC
Nov 14, 20254:54 PM ETNantahala Capital Management, LLCand 2 others13G/A9.39%1.24M shares+0.96 ppfrom 8.43%Sep 30, 2025SEC
Nov 14, 20254:12 PM ETRa Capital Management, L.P.and 3 others13G/A9.90%1.39M shares0.00 ppfrom 9.90%Sep 30, 2025SEC

Form 144: proposed insider sales

16 notices from officers, directors and other affiliates planning to sell Avalo Therapeutics, Inc. shares, newest first.

Form 144 notices for AVTX
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Aug 18, 20264:18 PM ETChristopher Ryan SullivanOfficer31.0K$622.2KAug 18, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Aug 17, 20264:49 PM ETMittie DoyleOfficer5.04K$98.7KAug 17, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Aug 17, 20264:47 PM ETChristopher Ryan SullivanOfficer70.7K$1.39MAug 17, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Aug 17, 20264:18 PM ETChristopher Ryan SullivanOfficer3.75K$74.8KAug 17, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Aug 11, 20264:22 PM ETJennifer RileyOfficer2.65K$52.0KAug 11, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Aug 10, 20264:47 PM ETMittie DoyleOfficer679$12.4KAug 10, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Jun 2, 20264:08 PM ETJonathan GoldmanDirector42.8K$616.2KJun 2, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
May 7, 20264:20 PM ETChristopher SullivanOfficer18.6K$405.8KMay 7, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
May 6, 20264:54 PM ETMittie DoyleOfficer54.5K$886.3KMay 6, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
May 6, 20264:32 PM ETChristopher SullivanOfficer47.0K$764.2KMay 6, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
May 6, 20264:30 PM ETPaul VarkiOfficer92.8K$1.51MMay 6, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
May 6, 20264:29 PM ETMitchell ChanDirector3.17K$51.5KMay 6, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Apr 29, 20264:33 PM ETChristopher SullivanOfficer16.9K$217.5KApr 29, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Apr 6, 20264:34 PM ETMittie DoyleOfficer65.8K$1.17MApr 6, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Apr 1, 20264:48 PM ETChristopher SullivanOfficer16.0K$238.3KApr 1, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Mar 16, 20264:39 PM ETMittie DoyleOfficer29.5K$466.6KMar 16, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC